Stock VO2 VO2 CAP HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Vo2 Cap Holding AB

Equities

VO2

SE0016802797

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm
Other stock markets
 05:57:30 2024-04-30 EDT 		5-day change 1st Jan Change
2.9 SEK -3.33% Intraday chart for Vo2 Cap Holding AB -2.36% -0.68%
2023 Ratsave AB acquired additional minority stake in Vo2 Cap Holding AB (OM:VO2) from Oskar Sardi. CI
2023 Vo2 Cap Holding AB (OM:VO2) entered into an agreement to acquire Madington Ab for SEK 65 million. CI

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 156.2 155.1 155.1 -
Enterprise Value (EV) 1 156.2 155.1 261.1 222.1
P/E ratio - 29 x 14.5 x 6.3 x
Yield - - - -
Capitalization / Revenue 0.33 x 0.45 x 0.38 x 0.34 x
EV / Revenue 0.33 x 0.45 x 0.64 x 0.49 x
EV / EBITDA - 10 x 7.46 x 4.35 x
EV / FCF - 95.4 x -131 x 5.84 x
FCF Yield - 1.05% -0.77% 17.1%
Price to Book - 0.64 x 0.66 x 0.6 x
Nbr of stocks (in thousands) 53,481 53,481 53,481 -
Reference price 2 2.920 2.900 2.900 2.900
Announcement Date 23-02-10 24-02-09 - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales 1 466.7 345 409 455
EBITDA 1 - 15.5 35 51
EBIT 1 - -31.74 16 33
Operating Margin - -9.2% 3.91% 7.25%
Earnings before Tax (EBT) 1 - 4.26 14 31
Net income 1 13.22 5.563 11 25
Net margin 2.83% 1.61% 2.69% 5.49%
EPS 2 - 0.1000 0.2000 0.4600
Free Cash Flow 1 - 3 -2 38
FCF margin - 0.74% -0.49% 8.35%
FCF Conversion (EBITDA) - 7.32% - 74.51%
FCF Conversion (Net income) - 18.75% - 152%
Dividend per Share - - - -
Announcement Date 23-02-10 24-02-09 - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt 1 - 131 106 67
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) - 3.195 x 3.029 x 1.314 x
Free Cash Flow 1 - 3 -2 38
ROE (net income / shareholders' equity) - 7% 5% 10%
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share 2 - 4.510 4.400 4.860
Cash Flow per Share - - - -
Capex 1 - 1 1 1
Capex / Sales - 0.25% 0.24% 0.22%
Announcement Date 23-02-10 24-02-09 - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Vo2 Cap Holding AB

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

1st Jan change Capi.
VO2 CAP HOLDING AB Stock Vo2 Cap Holding AB
-0.68% 14.68M
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
+3.14% 32.58B
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+16.26% 7.65B
SECTRA AB Stock Sectra AB
+21.60% 3.92B
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-16.02% 3.19B
OMNICELL, INC. Stock Omnicell, Inc.
-28.75% 1.26B
LUNIT INC. Stock Lunit Inc.
-31.01% 1.14B
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-34.81% 926M
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
+1.34% 908M
VERADIGM INC. Stock Veradigm Inc.
-23.83% 859M
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. VO2 Stock
  4. Financials Vo2 Cap Holding AB